Floatz logo

Benadryl

Primary CNS Lymphoma (PCNSL)

Hyungwoo ChoPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Primary CNS Lymphoma (PCNSL) cohort.

Asset / SponsorPhaseRating
Teniposide
Huashan Hospital
Phase 4BB
Fotemustine
Mingzhi Zhang
Phase 4BB
Epcoritamab
The Lymphoma Academic Research Organisation
Phase 2B
Anbalcabtagene Autoleucel
Hyungwoo Cho
Phase 2CCC
nb02
NOBO Medicine
Phase 2CCC

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Hodgkin LymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →